Blog

BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001

Apr 3 • 4 min read

VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce the closing of $1.168 million of convertible debentures to further advance the development of its lead compound,…

MindMed Shifts Focus to Nasdaq

Apr 2 • 3 min read

Mind Medicine (MindMed) Inc. has decided to streamline its trading avenues by voluntarily withdrawing its common shares from the Cboe Canada listing, a decision set to take effect after the market closes on April 10, 2024. This move is not an end but a strategic pivot, as MindMed emphasizes its continued presence on The Nasdaq…

Compass Pathways Lost Its Co-Founders – Now What?

Apr 2 • 4 min read

In an unexpected turn of events, Compass Pathways plc (Nasdaq: CMPS), a leading figure in the mental health sector, witnessed a notable dip in its stock price, plunging over 12% following the announcement of its co-founders, George Goldsmith and Ekaterina Malievskaia, stepping down from the board. This significant development unfolds as the company advances through…

Buftoad: A Meme Coin for Psychedelics

Apr 2 • 3 min read

In a world where meme coins often surface with the promise of quick riches but little substance, Buftoad emerges as a beacon of purpose and potential. Launched on the vibrant Solana blockchain, this innovative meme coin quickly turned heads, not just for its financial allure but for its noble mission. At its heart, Buftoad aims…

PsyCan Welcomes Expansion of Insurance Coverage for Psychedelic-Assisted Therapy in Alberta

Apr 2 • 2 min read

OTTAWA, April 02, 2024 (GLOBE NEWSWIRE) — PsyCan, the not-for-profit trade association for the legal Canadian psychedelic medicine industry, welcomes the expansion of insurance coverage for psychedelic-assisted therapy (PaT) led by the Alberta Blue Cross. “We welcome Alberta Blue Cross as the first major provincial insurer to cover Psychedelic-Assisted Therapy in all of its forms,” said…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561